News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
Photo: investor.agenusbio.com
Apr 18, 2025, 01:17

Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025

Agenus shared a post on LinkedIn:

“Stay tuned for AACR25, where Dr. Anthony El-khoueiry will present data from our Phase 1 trial evaluating botensilimab/balstilimab in treatment-refractory hepatocellular carcinoma (HCC).

Learn more.”

More posts featuring Agenus.

AACR25 Agenus Anthony El-Khoueiry cancer HCC hepatocellular carcinoma OncoDaily Oncology
Special Coverage
Voices
Aug 24, 2025, 19:14
Aakash Desai Highlighted JTO Study on MTAP as Biomarker in NSCLC
Voices
Aug 24, 2025, 18:48
Douglas Flora Highlights the Power of Early Cancer Detection and the Need for Policy Change
Voices
Aug 24, 2025, 18:41
Launching a New eBook for Patient Empowerment - Society for Integrative Oncology
Career Updates
Aug 24, 2025, 18:34
Conquer Cancer Welcomes Darby Joyce Seftor to the Team
Voices
Aug 24, 2025, 18:06
Jia Liu: Remembering Gary Mar’s Legacy of Advocacy in Head and Neck Cancer
Voices
Aug 24, 2025, 18:04
Chris McKee: MD Anderson Hosts Regional Training on Breast Imaging for Latin American Colleagues
Insight
Aug 24, 2025, 17:46
A New Viewpoint on the Role of Common Sense Oncology in the Western Pacific - CSO
Voices
Aug 24, 2025, 17:38
Meet the Stories Behind WeAllLiveIt - Childhood Cancer International
Voices
Aug 24, 2025, 17:28
Redressing the Manneken Pis as a Paediatric Oncologist for the Gold September - SIOP Europe
Blog Posts
Aug 24, 2025, 17:21
Norman Ng: Ensuring that Lung Cancer Patients Are Given a Fighting Chance
Voices
Aug 24, 2025, 17:13
Juan W Valle: Digital and Biological Twins in Cholangiocarcinoma
Science
Aug 24, 2025, 17:03
Saheli Sadanand Highlights a Study on CAR T Cells Showing Promise in High-Risk Neuroblastoma